by Francisca Peixoto | Dec 7, 2023 | Uncategorized
Boston Consulting Group (BCG) made an interesting article showing #DeepTech VC funds have similar returns to traditional VC, despite the high complexity and cash needs of building hardware and #biomolecules. #DrugDevelopment has no shortage of complexity or investment...
by Francisca Peixoto | Oct 19, 2023 | Uncategorized
Our portfolio company Macomics just appointed Kevin Lee as Independent Non-Executive Director. Kevin brings over two decades of invaluable biotech and pharma experience to Macomics’ team. He has been CEO at Bicycle Therapeutics since 2015, steering the company...
by Francisca Peixoto | Oct 16, 2023 | Uncategorized
Pablo holds a Master’s degree in Stem Cells and Regenerative Therapies from King’s College London, and a Bachelor’s degree in Biomedical Sciences from Royal Holloway University of London. His academic journey has equipped him with a thorough understanding of the...
by Francisca Peixoto | Sep 13, 2023 | Uncategorized
Our portfolio company Macomics published in Nature’s Biopharma Dealmakers September issue withe the article “Harnessing the Power of Macrophage Drug Discovery”. The article provides an overview of the company and the power and application of our...
by Francisca Peixoto | Aug 31, 2023 | Uncategorized
Our portfolio company Spiral Therapeutics has secured additional funding, led by Esperante & Ferring Ventures. Spiral Therapeutics is a clinical-stage company focused on delivering therapies for inner ear disorders. Spiral’s novel drug delivery platform...
by Francisca Peixoto | Jul 7, 2023 | Uncategorized
Our portfolio company Macomics was voted as Winner of One Nucleus BioNewsRound Award 2023 for Translational Research. Macomics is an immuno-oncology company with world-leading expertise in macrophage biology, developing precision medicines to modulate macrophages for...